Virani Shafique
Officer at RXRX
- Sold, on record
- $4.2M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Jan 16, 2024
- Form 144 notices
- 14
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RXRXRECURSION PHARMACEUTICALS, INC.Officer
Sales by reason
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 144 notice RXRXNoticeOct 16, 2023 2023
Filed to sell 18,000 shares ($113k)
Virani Shafique, Officer
10b5-1 plan1x usual sizeFiling
- 2 Form 4 sale RXRXRoutineOct 16, 2023 same day
Sold 18,000 shares at $6.30 ($113k)
Virani Shafique, Chief Business Officer
10b5-1 planSold 11.4% of holdings ($998k position)140,351 shares left1x usual sizeFollows a Form 144Filing
- 3 Form 144 notice RXRXNoticeNov 15, 2023 +30 days
Filed to sell 18,000 shares ($117k)
Virani Shafique, Officer
10b5-1 plan1x usual sizeFiling
- 4 Form 4 sale RXRXRoutineNov 15, 2023 same day
Sold 18,000 shares at $6.51 ($117k)
Virani Shafique, Chief Business Officer
10b5-1 planSold 11.4% of holdings ($1M position)140,351 shares left1x usual sizeFollows a Form 144Filing
- 5 Form 144 notice RXRXNoticeDec 15, 2023 +30 days
Filed to sell 18,000 shares ($171k)
Virani Shafique, Officer
10b5-1 plan1x usual sizeFiling
- 6 Form 4 sale RXRXRoutineDec 15, 2023 same day
Sold 18,000 shares at $9.60 ($173k)
Virani Shafique, Chief Business Officer
10b5-1 planSold 11.6% of holdings ($1.5M position)136,748 shares left1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice RXRXNoticeJan 16, 2024 +32 days
Filed to sell 18,000 shares ($197k)
Virani Shafique, Officer
10b5-1 plan1x usual sizeFiling
- 8 Form 4 sale RXRXRoutineJan 16, 2024 same day
Sold 18,000 shares at $10.93 ($197k)
Virani Shafique, Chief Business Officer
10b5-1 planSold 11.6% of holdings ($1.7M position)136,748 shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (31)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | Jan 18, 2024 | RXRX | Chief Business Officer | Form 4 sale | 18,000 | $197k | 11.6% | Routine | SEC |
| Jan 16, 2024 | Jan 16, 2024 | RXRX | Officer | Form 144 notice | 18,000 | $197k | Notice | SEC | |
| Dec 15, 2023 | Dec 19, 2023 | RXRX | Chief Business Officer | Form 4 sale | 18,000 | $173k | 11.6% | Routine | SEC |
| Dec 15, 2023 | Dec 15, 2023 | RXRX | Officer | Form 144 notice | 18,000 | $171k | Notice | SEC | |
| Nov 15, 2023 | Nov 17, 2023 | RXRX | Chief Business Officer | Form 4 sale | 18,000 | $117k | 11.4% | Routine | SEC |
| Nov 15, 2023 | Nov 15, 2023 | RXRX | Officer | Form 144 notice | 18,000 | $117k | Notice | SEC | |
| Oct 16, 2023 | Oct 18, 2023 | RXRX | Chief Business Officer | Form 4 sale | 18,000 | $113k | 11.4% | Routine | SEC |
| Oct 16, 2023 | Oct 16, 2023 | RXRX | Officer | Form 144 notice | 18,000 | $113k | Notice | SEC | |
| Sep 15, 2023 | Sep 19, 2023 | RXRX | Chief Business Officer | Form 4 sale | 18,000 | $156k | 11.4% | Routine | SEC |
| Sep 15, 2023 | Sep 15, 2023 | RXRX | Officer | Form 144 notice | 18,000 | $156k | Notice | SEC | |
| Aug 15, 2023 | Aug 17, 2023 | RXRX | Chief Business Officer | Form 4 sale | 18,000 | $167k | 11.4% | Routine | SEC |
| Aug 15, 2023 | Aug 15, 2023 | RXRX | Officer | Form 144 notice | 18,000 | $167k | Notice | SEC | |
| Jul 26, 2023 | Jul 27, 2023 | RXRX | Chief Business Officer | Form 4 sale | 40,000 | $574k | 21.7% | Unusual | SEC |
| Jul 26, 2023 | Jul 26, 2023 | RXRX | Officer | Form 144 notice | 20,000 | $288k | Notice | SEC | |
| Jul 25, 2023 | Jul 25, 2023 | RXRX | Officer | Form 144 notice | 20,000 | $286k | Notice | SEC | |
| Jul 18, 2023 | Jul 19, 2023 | RXRX | Chief Business Officer | Form 4 sale | 60,000 | $764k | 29.4% | Unusual | SEC |
| Jul 18, 2023 | Jul 18, 2023 | RXRX | Officer | Form 144 notice | 30,000 | $412k | Notice | SEC | |
| Jul 17, 2023 | Jul 17, 2023 | RXRX | Officer | Form 144 notice | 30,000 | $352k | Notice | SEC | |
| Jun 16, 2023 | Jun 20, 2023 | RXRX | Chief Business Officer | Form 4 sale | 60,000 | $572k | 29.4% | Unusual | SEC |
| Jun 16, 2023 | Jun 16, 2023 | RXRX | Officer | Form 144 notice | 30,000 | $282k | Notice | SEC | |
| Jun 15, 2023 | Jun 15, 2023 | RXRX | Officer | Form 144 notice | 30,000 | $290k | Notice | SEC | |
| Jun 2, 2023 | Jun 5, 2023 | RXRX | Chief Business Officer | Form 4 sale | 42,865 | $374k | 22.9% | Unusual | SEC |
| Jun 2, 2023 | Jun 2, 2023 | RXRX | Officer | Form 144 notice | 17,865 | $160k | Notice | SEC | |
| Jun 1, 2023 | Jun 1, 2023 | RXRX | Officer | Form 144 notice | 25,000 | $215k | Notice | SEC | |
| Feb 16, 2023 | Feb 17, 2023 | RXRX | Chief Business Officer | Form 4 sale | 9,254 | $77k | 4.7% | Plan not stated | SEC |
| Jan 17, 2023 | Jan 19, 2023 | RXRX | Chief Business Officer | Form 4 sale | 10,000 | $92k | 12.0% | Plan not stated | SEC |
| Dec 15, 2022 | Dec 19, 2022 | RXRX | Chief Business Officer | Form 4 sale | 10,000 | $89k | 11.3% | Plan not stated | SEC |
| Nov 15, 2022 | Nov 17, 2022 | RXRX | Chief Business Officer | Form 4 sale | 10,000 | $123k | 10.7% | Plan not stated | SEC |
| Oct 14, 2022 | Oct 18, 2022 | RXRX | Chief Business Officer | Form 4 sale | 10,000 | $109k | 10.1% | Plan not stated | SEC |
| Sep 15, 2022 | Sep 16, 2022 | RXRX | Chief Business Officer | Form 4 sale | 10,000 | $134k | 9.6% | Plan not stated | SEC |
| Aug 16, 2022 | Aug 17, 2022 | RXRX | Chief Business Officer | Form 4 sale | 30,000 | $378k | 23.3% | Plan not stated | SEC |